23 March 1990
COMMERCIAL ITEM DESCRIPTION
DIMENHYDRINATE TABLETS, USP
The General Services Administration has authorized the use of this Commercial Item Description as a replacement for Military Specification MIL-D-37615 which is cancelled.
Shall be Dimenhydrinate Tablets, USP.
Shall contain 50 mg Dimenhydrinate per tablet within the applicable assay limits for the tablets.
Shall be in accordance with the requirements of the USP.
Material used in manufacture shall be of pharmaceutical grade.
Each tablet shall be marked/embossed with a product identification code to identify the active ingredient(s) strength, and manufacturer. The materials used in marking/embossing the dosage forms shall be acceptable to the FDA. The actual code used for the product shall be left to the discretion of the supplier.
Workmanship. The tablets shall be free from defects which detract from their appearance or impair their serviceability.
Unit. Bottle (BT). One bottle containing 100 tablets, as specified, constitutes one unit.
Contractor certification. The contractor shall certify that the product offered meets the salient characteristics of this description and conforms to the producersí own drawings, specifications, standards, and quality assurance practices. The Government reserves the right to require proof of such conformance prior to first delivery and thereafter as may be otherwise provided for under the provisions of the contract.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business